Cambridge Investment Research Advisors
CLB icon

Cambridge Investment Research Advisors’s Core Laboratories CLB Stock Holding History

Cambridge Investment Research Advisors’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-2,775
Closed -$406K – 1385
2014
Q3 		$406K Buy
2,775
+518
+23% +$80K 0.01% 926
2014
Q2 		$377K Buy
2,257
+424
+23% +$75.4K 0.01% 888
2014
Q1 		$364K Buy
1,833
+256
+16% +$48.3K 0.01% 861
2013
Q4 		$301K Buy
1,577
+167
+12% +$31.1K 0.01% 883
2013
Q3 		$239K Buy
1,410
+33
+2% +$5.12K 0.01% 955
2013
Q2 		$209K Buy
+1,377
New +$195K 0.01% 932

Other funds holding CLB

ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
WP
Wedgewood Partners St Louis, Missouri $484M AUM 14.59% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Cambridge Investment Research Advisors's CLB Position: Q4 2014 in Review

Cambridge Investment Research Advisors sold out of Core Laboratories (CLB) in Q4 2014, closing a stake of 2,775 shares — an estimated $406K sold.

Cambridge Investment Research Advisors first reported a position in CLB in Q2 2013 and held it in 6 quarters. The position peaked at $406K in Q3 2014. 345 funds tracked by Wall St. Rank hold CLB as of Q4 2014.

  • Cambridge Investment Research Advisors reported no remaining Core Laboratories position as of Q4 2014 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 2,775 Core Laboratories shares in Q4 2014, an estimated $406K.
  • Cambridge Investment Research Advisors first reported a position in Core Laboratories in Q2 2013 and held it in 6 quarters.
  • Cambridge Investment Research Advisors's Core Laboratories position peaked at $406K in Q3 2014.
  • 345 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2014.

Based on Cambridge Investment Research Advisors's 13F filing for Q4 2014, filed 6 Feb 2015.